Additionally, novel insights recently reported by our group demonstrate that a DVL-1 post-translational acetylation promotes nuclear localization in triple-negative breast cancer, highlighting a novel molecular switch that regulates subcellular localization of DVL proteins [9]. This evidence concerns the gene DVL1 and triple-negative breast carcinoma.